Pharmacokinetic Concentrations
adpcA data frame with 128 columns:
Study Identifier
Unique Subject Identifier
Subject Identifier for the Study
Study Site Identifier
Country
Subject Reference Start Date/Time
Subject Reference End Date/Time
Date/Time of First Study Treatment
Date/Time of Last Study Treatment
Date/Time of End of Participation
Screen Failure Date
Final Retrieval Visit Date
Date/Time of Death
Relative Day of Death
Subject Death Flag
Elapsed Days from Last Dose to Death
Last Dose to Death - Days Elapsed Grp 1
Under 30 Group
Over 30 Group
Domain for Date of Death Collection
Over 30 plus 30 days Group
Analysis Sequence Number
Geographic Region 1
Date/Time of Collection
Study Day of Collection
Age
Age Units
Pooled Age Group 1
Sex
Race
Pooled Race Group 1
Ethnicity
Safety Population Flag
Description of Planned Arm
Planned Arm Code
Description of Actual Arm
Actual Arm Code
Planned Treatment for Period 01
Actual Treatment for Period 01
Date of First Exposure to Treatment
Datetime of First Exposure to Treatment
Time of First Exposure Imput. Flag
Date of Last Exposure to Treatment
Datetime of Last Exposure to Treatment
Time of Last Exposure Imput. Flag
End of Study Status
End of Study Date
Date/Time of Informed Consent
Date of Randomization
Date Last Known Alive
Total Treatment Duration (Days)
Date of Death
Date of Death Imputation Flag
Cause of Death
Cause of Death Reason 1
Planned Treatment Dose
Actual Treatment Dose
Treatment Dose Units
Analysis Date
Analysis Time
Analysis Datetime
Analysis Relative Day
Analysis Time Imputation Flag
Analysis Start Date
Analysis Start Time
Analysis Start Datetime
Analysis End Date
Analysis End Time
Analysis End Datetime
Analysis Visit
Analysis Visit (N)
Analysis Timepoint
Analysis Timepoint (N)
Analysis Timepoint Reference
Parameter
Parameter Code
Parameter (N)
Parameter Category 1
Analysis Value
Analysis Value Unit
Analysis Value Category 1
Baseline Value
Baseline Type
Change from Baseline
Derivation Type
Baseline Record Flag
Analysis Flag 01
Analysis Flag 02
Source Data
Source Variable
Source Sequence Number
Nom. Rel. Time from Analyte First Dose
Pharmacokinetic Test Short Name
Pharmacokinetic Test Name
Result or Finding in Original Units
Original Units
Character Result/Finding in Std Format
Numeric Result/Finding in Standard Units
Standard Units
Vendor Name
Specimen Material Type
Lower Limit of Quantitation
Visit Name
Visit Number
Planned Study Day of Visit
Date/Time of Specimen Collection
Actual Study Day of Specimen Collection
Planned Time Point Name
Planned Time Point Number
First Datetime of Dose for Analyte
Act. Rel. Time from Analyte First Dose
Actual Rel. Time from Ref. Dose
Reference Datetime of Dose for Analyte
First Date of Dose for Analyte
First Time of Dose for Analyte
Reference Date of Dose for Analyte
Reference Time of Dose for Analyte
Nominal Rel. Time from Ref. Dose
Rel. Time from First Dose Unit
Rel. Time from Ref. Dose Unit
Analysis Lower Limit of Quantitation
Modified Rel. Time from Ref. Dose
Numeric Result/Finding in Standard Units
Standard Units
Numeric Result/Finding in Standard Units
Standard Units
Baseline Body Mass Index (kg/m2)
BMI at Baseline (Unit)
Contains a set of 2 unique Parameter Codes and Parameters:
| PARAMCD | PARAM |
| DOSE | Xanomeline Patch Dose |
| XAN | Pharmacokinetic concentration of Xanomeline |
None